Health Affairs

Health Affairs, 26, no. 1 (2007): 25-37 doi: 10.1377/hlthaff.26.1.25 © 2007 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Weisfeldt, M. L. Articles by Zieman, S. J. Search for Related Content PubMed PubMed Citation Articles by Weisfeldt, M. L. Articles by Zieman, S. J. Related Collections Health Promotion/Disease Prevention Pharmaceuticals Chronic Care Research And Technology Consumer Issues Cardiovascular Disease Related Blog Posts

Trends

Advances In The Prevention And Treatment Of Cardiovascular Disease

Myron L. Weisfeldt and Susan J. Zieman

Over the past thirty-five years, U.S. age-adjusted mortality from cardiovascular disease declined 50 percent. This marked reduction reflects advances in the prevention, diagnosis, and treatment of common cardiovascular conditions. Pharmaceutical agents play a major role in prevention of atherosclerosis and its consequences: heart attack, stroke, and heart failure. Additionally, novel device-based therapies contribute to the decline in cardiac morbidity and mortality. Whereas innovative strategies based on accurate imaging of the heart and blood vessels are implemented widely now, hope exists that lifestyle changes, early risk-factor screening, and more efficacious drugs will strikingly reduce cardiovascular disease in the future.

                      What's this?

Related Blog Posts:

This article has been cited by other articles:

				J. T. Dove, W. D. Weaver, and J. Lewin Professional accountability in health system reform. J. Am. Coll. Cardiol., August 4, 2009; 54(6): 499 - 501. [Abstract] [Full Text] [PDF]

				R. A. Rosenheck, D. L. Leslie, and J. A. Doshi Second-Generation Antipsychotics: Cost-Effectiveness, Policy Options, and Political Decision Making Psychiatr Serv, May 1, 2008; 59(5): 515 - 520. [Abstract] [Full Text] [PDF]